1.Keratoacanthoma Centrifugum Marginatum.
You Chan KIM ; Hwan Pyo JEON ; Kwang Hyun CHO ; Yoo Shin LEE
Annals of Dermatology 1989;1(1):40-42
No abstract available.
Keratoacanthoma*
2.A Case of Exophytic Pilomatricoma Clinically Resembling Keratoacanthoma.
Seung Hyun CHUN ; Chang Min KIM ; Ji Min LEE ; Il Hwan KIM
Annals of Dermatology 2017;29(2):258-260
No abstract available.
Keratoacanthoma*
;
Pilomatrixoma*
3.A Case of Solitary Keratoacanthoma Originated from Verruca Vulgaris.
Yoon Sung PARK ; Soo Il CHUN ; Chang Jo KOH
Korean Journal of Dermatology 1984;22(3):334-337
Keratoacanthoma is a benign neoplasm that develops as a protruding mass especially on the central part of face, We experienced a case of keratoacanthoma that developed on the nasal vestibule after the eradication of verruca vulgaris on the same site by surgical intervention 3 months before. We treated it with total excision and skin graft.
Keratoacanthoma*
;
Skin
;
Transplants
;
Warts*
4.Successful Treatment of Two Cases of Keratoacanthomas with Intralesional Methotrexate.
Dong O YOU ; Nyoung Hoon YOUN ; Seok Don PARK
Korean Journal of Dermatology 2002;40(5):555-558
Keratoacanthoma is a rapidly growing tumor that has the tendency of spontaneous involution but it may persist for some times, continue to enlarge and may become invasive and destructive. Many modalities are available for the treatment of keratoacanthoma. Although excisional surgery is the treatment of choice, this can result in functional and cosmetic defects when large or strategically located lesions are treated. An effective nonsurgical treatment would be desirable in such cases. We report two cases with unusually large or facial keratoacanthoma treated with intralesional methotrexate. One case showed complete resolution over 6 injections and the other after 2 injections. We suggest that intralesional injection of methotrexate is a simple, effective, safe and inexpensive method for the treatment of large keratoacanthoma.
Injections, Intralesional
;
Keratoacanthoma*
;
Methotrexate*
5.Cutaneous Horn Arising from Keratoacanthoma.
Woong Suk CHAE ; Jun Young SEONG ; Ha Na JUNG ; Ho Seok SUH ; Yu Sung CHOI
Korean Journal of Dermatology 2014;52(10):767-768
No abstract available.
Animals
;
Horns*
;
Keratoacanthoma*
6.A Case of Keratoacanthoma Associated with Basal Cell Carcinoma.
Tae Hyung KIM ; Ji Hye LEE ; Mi Ryung ROH
Annals of Dermatology 2015;27(2):237-238
No abstract available.
Carcinoma, Basal Cell*
;
Keratoacanthoma*
7.A Case of Keratoacanthoma at the Nasal Vestibule.
Nayeon CHOI ; Seung Kyu CHUNG ; Hun Jong DHONG ; Hyo Yeol KIM
Journal of Rhinology 2013;20(2):149-152
Keratoacanthoma is the epidermal tumor characterized by the benign course such as rapid growth and spontaneous resolution. Rarely keratoacanthoma invades adjacent structures. Therefore, controversies have arisen about the biologic behavior whether keratoacanthoma is a benign tumor or a variant of low grade cutaneous squamous cell carcinoma. We report a case of the recurred keratoacanthoma at the nasal vestibule treated with the surgical excision and the reconstruction by local bilobed rotation flap in a 54-year old female whose final pathology was confirmed as well differentiated squamous cell carcinoma.
Carcinoma, Squamous Cell
;
Female
;
Humans
;
Keratoacanthoma*
;
Pathology
8.Treatment of Keratoacanthoma by 5-Fluorouracil Intralesional Injection.
Sung Jun KIM ; Ho Sun JANG ; Chang Keun OH ; Kyung Sool KWON
Korean Journal of Dermatology 2001;39(8):942-945
Keratoacanthoma is a not uncommon skin tumor characterized by rapid growth of a smooth dome-shaped nodule with a central plug of keratin, usually followed by spontaneous involution. Because the tumor leaves a nunsightly scar, this is one of the reasons why these lesions should be treated. Excision is desirable if the diagnosis is in doubt. But surgical removal may be difficult, alternative treatment approaches should be considered. We report two cases of keratocathoma successfully treated by intralesional injection of 5-fluorouracil.
Cicatrix
;
Diagnosis
;
Fluorouracil*
;
Injections, Intralesional*
;
Keratoacanthoma*
;
Skin
9.Treatment of Keratoacanthoma with 5% Imiquimod Cream.
Na Young KO ; Jun Ha PARK ; Sang Wook SON ; Il Hwan KIM
Annals of Dermatology 2006;18(1):14-17
Keratoacanthoma is a rapidly growing tumor that histologically resembles squamous cell carcinoma. Surgical excision is a desirable therapeutic option, but several other treatment modalities are available. We report on two cases of keratoacanthoma that were treated with imiquimod 5% cream. Imiquimod was applied daily for the first 6 or 7 days, and then reduced to alternate days according to the tolerance and erythema severity of the patient. In both patients, the tumors fully regressed after five weeks of treatment.
Carcinoma, Squamous Cell
;
Erythema
;
Humans
;
Keratoacanthoma*
10.A Case of Cutaneous Horn Originating from Keratoacanthoma.
Jung Hoon YANG ; Dae Hyun KIM ; Jong Suk LEE ; Moon Kyun CHO ; Sang Hoon LEE ; Sung Yul LEE ; Hyun Deuk CHO
Annals of Dermatology 2011;23(1):89-91
Cutaneous horn is the clinical description of a hyperproliferation of compact keratin in response to a wide array of underlying benign and malignant pathologic changes. We report here on a case of cutaneous horn that originated from keratoacanthoma in a 76-year-old woman. Grossly, a 2.5x0.7 cm sized yellow-white colored scaly fungating mass from an erythematous nodule was observed on the right temporal area. Histopathologically, it was reported as keratoacanthoma with cutaneous horn. The lesion was totally excised after the diagnosis.
Aged
;
Animals
;
Female
;
Horns
;
Humans
;
Keratins
;
Keratoacanthoma